Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04715412
Status:
COMPLETED
Last Update Posted:
2021-01-20
First Post:
2021-01-14
Brief Title:
Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients
Sponsor:
Future University in Egypt
Organization:
Future University in Egypt
Study Overview
Official Title:
Impact of Clinical Pharmacy Guided Patient Counseling and Adherence Support on Renal Transplant Recipients Adherence and Health Outcomes
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
As a result of the shortage of donor organs and the close relationship between allograft or even life loss and non-adherence after kidney transplantation improvement of patient adherence appears essential So the current study aimed to monitor adherence barriers of renal transplant recipients and evaluate possible consequences of nonadherence on recipients clinical outcomes as well as to implement a structured adherence management program consisting of intensified patient counselling and adherence support by a dedicated clinical pharmacist as an adjunct to standard post-transplant patient education carried out by transplant physicians to investigate the efficacy of the implemented program on patients adherence and health outcomes as compared to standard physician patient care The study is a prospective self-controlled interventional study that recruited 69 living donors-renal transplant Patients attending the transplant clinic of Nasser institute and satisfying the inclusion criteria On enrolment patient-related baseline data that could determine and affect patients adherence as well as patients clinical outcomes were recorded After all patients received the adjuvant adherence management program by the clinical pharmacist for 6 month patients health outcomes were re-evaluated to compare them to baseline data
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None